(D-ALA1)-Peptide T: A Promising Antiviral Agent for AIDS Research

Discover the potential of (D-ALA1)-Peptide T, a synthetic octapeptide that mimics HIV envelope protein gp120. Explore its antiviral properties and applications in AIDS therapy. Partner with a trusted supplier for high-purity peptides.

Get a Quote & Sample

Key Advantages of (D-ALA1)-Peptide T

Targeted Antiviral Mechanism

Investigate how (D-ALA1)-Peptide T, with its homology to HIV gp120, interferes with viral entry by targeting the CD4 receptor, a crucial step in AIDS therapy development.

Enhanced Stability and Purity

Utilize a compound with a confirmed purity of ≥98.0% and desirable physical properties, ensuring reproducible results in your scientific endeavors.

Versatile Research Applications

Employ (D-ALA1)-Peptide T in various biochemical and immunological applications, supporting cutting-edge research in virology and drug discovery.

Applications in Pharmaceutical Research

Antiviral Drug Development

Discover the use of (D-ALA1)-Peptide T as a crucial building block for new antiviral drugs aimed at treating HIV and other viral infections.

AIDS Therapy Research

Explore how this synthetic octapeptide contributes to understanding and developing treatments for AIDS by blocking viral attachment to CD4 receptors.

Biochemical Tool

Utilize (D-ALA1)-Peptide T as a molecular tool in various biochemical assays and research projects aimed at understanding cellular interactions.

Custom Synthesis Projects

Inquire about custom synthesis services for specific research requirements, ensuring you get the exact peptide formulations needed.